Evidence map›Paper›PMID 36518395›Full record

ArticleToxicology reports2022

Adjuvants in fungicide formulations can be skin sensitizers and cause different types of cell stress responses.

Renato Ivan de Ávila, Sofía Carreira Santos, Valentina Siino, Fredrik Levander, Malin Lindstedt, Kathrin S Zeller

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Renato Ivan de ÁvilaLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Sofía Carreira SantosLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Valentina SiinoLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Fredrik LevanderLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Malin LindstedtLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Kathrin S ZellerLund University, Department of Immunotechnology, Medicon Village, House 406, 22387 Lund, Sweden.
Lund University · SEMedicon Village · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New approaches based on -omics technologies can identify biomarkers and processes regulated in response to xenobiotics, and thus support toxicological risk assessments. This is vital to meet the challenges associated with "cocktail effects", i.e. combination effects of chemicals present simultaneously in a product, our environment, and/or our body. For plant protection products (PPPs), investigations largely focus on active ingredients such as herbicides and fungicides. In this study, we have analyzed agricultural chemicals, two surfactants (poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-[2,4,6-tris(1-phenylethyl)phenoxy]-, ammonium salt, POL; N,N-dimethylcapramide, NND), and one preservative, 1,2-benzisothiazol-3(2 H)-one (BEN) used as adjuvants in PPPs, and further three fungicide PPPs, Proline EC 250, Shirlan, Folicur Xpert, containing the adjuvants, and other major individual constituents (fluazinam (FLU), prothioconazole (PRO), tebuconazole (TEB)) as well as defined mixtures ("mixes") thereof using several

Indexed as

Cocktail effectsImmunotoxicityin vitro modelsOmics approachesPlant protection productsSkin sensitization

Identifiers

PMID36518395
PMCPMC9742974
OpenAlexW4309279643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.